Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

September 2009

17

HRA Pharma Reinforces Operational Presence in Europe with Italian Subsid

July 2009

01

HRA Pharma Marks Next Step in European Expansion with UK Subsidiary.

June 2009

10

NorLevo®, HRA Pharma's Emergency Contraceptive Pill, Now Available in Canada.

May 2009

26

HRA Pharma Granted European Marketing Authorization for ellaOne®.

May 2009

11

HRA Pharma and Preglem Announce Successful Completion of Phase IIB for Ulipristal Acetate for the Treatment of Uterine Fibroids.

April 2009

28

HRA Pharma Appoints Erin Gainer as CEO to Lead Company Through Next Phases of International Growth.

April 2009

07

HRA Pharma and Nycomed Reinforce Partnership with Marketing and Distribution Agreement for ellaOne®

March 2009

20

HRA Pharma Receives CHMP Positive Opinion for ellaOne®

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?